Seminars in Hematology
Volume 47, Issue 3 , Pages 243-248, July 2010

Biology and Chemistry of Thrombopoietic Agents

  • David J. Kuter

      Affiliations

    • Corresponding Author InformationAddress correspondence to David J. Kuter, MD, DPhil, Hematology Division, Yawkey 7940, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114

Hematology Division, Massachusetts General Hospital, Boston, MA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by Grants No. HL82889 and HL072299 from the National Institutes of Health.

 Conflict of Interest Statement: The author has been a consultant to and received research funding from the following: Amgen, Inc.; GlaxoSmithKline, Inc.; Ligand Pharmaceuticals, Inc.; ONO Pharmaceuticals; Kirin Pharmaceuticals; Shionagi, Inc; Eisai, Inc.

PII: S0037-1963(10)00030-2

doi:10.1053/j.seminhematol.2010.02.005

Seminars in Hematology
Volume 47, Issue 3 , Pages 243-248, July 2010

Article Tools

* Image Usage & Resolution